41 minutes agoPolitics
38LENS
6 SourcesIdaho, United States
thebalanced.newsU.S. Reclassifies Medical Marijuana to Less Restrictive Schedule III Category
The U.S. government has reclassified FDA-approved and state-licensed medical marijuana from Schedule I, the most restrictive drug category, to Schedule III, which includes substances with lower abuse potential. This change, announced by Acting Attorney General Todd Blanche, does not legalize marijuana federally but eases research restrictions, reduces tax burdens, and may benefit cannabis companies. A hearing is scheduled for June to consider broader rescheduling, following President Trump's directive to expedite marijuana policy reform.
Political Bias
3%96%1%
Sentiment
69%
AI Analysis
Political bias across 6 sources
● Left 3%● Center 96%● Right 1%
The article group presents a range of perspectives focusing on federal policy changes under the Trump administration, highlighting official statements and industry reactions. Coverage includes government rationale for reclassification, business impacts, and ongoing regulatory processes, reflecting both supportive views on medical access and research expansion and acknowledgment of marijuana's continued federal illegality. The framing is largely policy- and fact-oriented without partisan editorializing.
Sentiment — Positive (69/100)
The overall tone across the articles is cautiously positive, emphasizing the policy shift as a significant step toward easing restrictions on medical marijuana. Coverage highlights benefits for research, patient access, and the cannabis industry, while maintaining a neutral stance on legalization. The sentiment balances optimism about regulatory progress with recognition of remaining legal limitations.
How 6 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| mint | US reclassifies some Marijuana products as less dangerous; hearing set for June 2026 Today News | Center | Neutral |
| theprint | US to loosen marijuana rules in major shift for 47 billion industry | Center | Positive |
| hindustantimes | US eases cannabis for medical use: Access, research, and regulation explained | Center | Positive |
| economictimes | Has Donald Trump administration made Marijuana legal for medical or recreational use in U.S.? Shares of cannabis firms jump big in U.S. Stock Market | Center | Positive |
| news18 | Weed Gets Relief In America: Why US Just Took Its Biggest Cannabis Step Yet | Center | Neutral |
| theprint | US reclassifies certain marijuana products as a less-dangerous drug | Center | Positive |
Coverage timeline
theprint broke this story on 23 Apr, 01:07 pm. Other outlets followed.
- 1theprint23 Apr, 01:07 pmUS reclassifies certain marijuana products as a less-dangerous drug
- 2news1823 Apr, 02:48 pmWeed Gets Relief In America: Why US Just Took Its Biggest Cannabis Step Yet
- 3economictimes23 Apr, 03:17 pmHas Donald Trump administration made Marijuana legal for medical or recreational use in U.S.? Shares of cannabis firms jump big in U.S. Stock Market
- 4hindustantimes23 Apr, 03:54 pmUS eases cannabis for medical use: Access, research, and regulation explained
- 5theprint23 Apr, 04:04 pmUS to loosen marijuana rules in major shift for 47 billion industry
- 6mint23 Apr, 04:24 pmUS reclassifies some Marijuana products as less dangerous; hearing set for June 2026 Today News
Lens Score breakdown
38/100
Public interest0/100
Coverage gap90%
Story is receiving appropriate media attention relative to public interest.
Who's involved
Institutions and figures named across source coverage.
Government
Justice DepartmentDepartment of JusticeOffice of the Acting Attorney GeneralFDAU.S. Drug Enforcement AdministrationFood and Drug AdministrationUS Federal Government
Corporate
Cronos GroupAurora CannabisVeranoTilray BrandsTrulieve CannabisCanopy Growth
Story context
- Category
- Politics
- Location
- Idaho, United States
- Sources analysed
- 6
- Last analysed
- 23 Apr 2026
- Key entities
- Controlled Substances ActCannabis (drug)United States Department of JusticeMedical cannabisFederal government of the United StatesDonald TrumpUnited States Attorney GeneralHeroinExecutive order (United States)Prohibition of drugsRecreational drug useFood and Drug Administration
Related Coverage
Select a news story to see related coverage from other media outlets.